ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 107 filers reported holding ACLARIS THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48,393,442 | +38.9% | 7,064,736 | +110.2% | 1.30% | +34.4% |
| Q2 2023 | $34,852,958 | +28.2% | 3,360,941 | 0.0% | 0.97% | -2.3% |
| Q1 2023 | $27,190,013 | -47.3% | 3,360,941 | +2.6% | 0.99% | -54.4% |
| Q4 2022 | $51,605,552 | -17.6% | 3,276,543 | -17.6% | 2.18% | -15.8% |
| Q3 2022 | $62,591,000 | +12.8% | 3,976,543 | 0.0% | 2.59% | -3.5% |
| Q2 2022 | $55,513,000 | -19.0% | 3,976,543 | 0.0% | 2.68% | -2.2% |
| Q1 2022 | $68,556,000 | +178.0% | 3,976,543 | +134.5% | 2.74% | +206.4% |
| Q4 2021 | $24,658,000 | -0.2% | 1,695,904 | +23.5% | 0.90% | -7.2% |
| Q3 2021 | $24,715,000 | +40.7% | 1,373,044 | +37.3% | 0.96% | +46.5% |
| Q2 2021 | $17,560,000 | – | 1,000,000 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 3,399,034 | $49,422,000 | 10.17% |
| VR Adviser, LLC | 4,563,962 | $66,360,000 | 9.07% |
| COMMODORE CAPITAL LP | 2,672,346 | $38,856,000 | 9.00% |
| TCG Crossover Management, LLC | 1,082,213 | $15,735,000 | 7.37% |
| Foresite Capital Management V, LLC | 1,258,243 | $18,295,000 | 4.50% |
| Parkman Healthcare Partners LLC | 1,025,522 | $14,911,000 | 3.29% |
| Aisling Capital Management LP | 634,455 | $9,225,000 | 3.25% |
| GREAT POINT PARTNERS LLC | 800,000 | $11,632,000 | 2.58% |
| Samsara BioCapital, LLC | 794,171 | $11,547,000 | 2.24% |
| Affinity Asset Advisors, LLC | 400,000 | $5,816,000 | 2.11% |